Cargando…

Antisense Inhibition of Angiotensinogen With IONIS-AGT-L(Rx): Results of Phase 1 and Phase 2 Studies

Targeting angiotensinogen (AGT) may provide a novel approach to more optimally inhibit the renin-angiotensin-aldosterone system pathway. Double-blind, placebo-controlled clinical trials were performed in subjects with hypertension as monotherapy or as an add-on to angiotensin-converting enzyme inhib...

Descripción completa

Detalles Bibliográficos
Autores principales:	Morgan, Erin S., Tami, Yvonne, Hu, Kuolung, Brambatti, Michela, Mullick, Adam E., Geary, Richard S., Bakris, George L., Tsimikas, Sotirios
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Elsevier 2021
Materias:	Clinical Research
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8246029/ https://www.ncbi.nlm.nih.gov/pubmed/34222719 http://dx.doi.org/10.1016/j.jacbts.2021.04.004

Ejemplares similares

Phase 2 Study of the Factor XI Antisense Inhibitor IONIS-FXI(Rx) in Patients With ESRD
por: Walsh, Michael, et al.
Publicado: (2021)

IONIS-PKK(Rx) a Novel Antisense Inhibitor of Prekallikrein and Bradykinin Production
por: Ferrone, Jason D., et al.
Publicado: (2019)

OR27-4 Placebo-Controlled and Open-Label Extension Study of a Novel Hepatic-Targeted Antisense Cimdelirsen (IONIS-GHR-LRx) Under Investigation in Acromegaly Patients
por: Bhanot, Sanjay, et al.
Publicado: (2022)

Design and Rationale of the Global Phase 3 NEURO-TTRansform Study of Antisense Oligonucleotide AKCEA-TTR-L(Rx) (ION-682884-CS3) in Hereditary Transthyretin-Mediated Amyloid Polyneuropathy
por: Coelho, Teresa, et al.
Publicado: (2021)

Antisense oligonucleotides targeting angiotensinogen: insights from animal studies
por: Wu, Chia-Hua, et al.
Publicado: (2019)

Effect of Hydrocortisone on Angiotensinogen (AGT) Mutation–Causing Autosomal Recessive Renal Tubular Dysgenesis
por: Tseng, Min-Hua, et al.
Publicado: (2021)

Integrated Assessment of Phase 2 Data on GalNAc(3)-Conjugated 2′-O-Methoxyethyl-Modified Antisense Oligonucleotides
por: Baker, Brenda F., et al.
Publicado: (2023)

Antisense oligonucleotides targeting hepatic angiotensinogen reduce atherosclerosis and liver steatosis in hypercholesterolemic mice
por: Ye, Dien, et al.
Publicado: (2023)

Angiotensinogen (AGT) M235T, AGT T174M and Angiotensin-1-Converting Enzyme (ACE) I/D Gene Polymorphisms in Essential Hypertension: Effects on Ramipril Efficacy
por: Kolovou, Vana, et al.
Publicado: (2015)

DNA Methylation of the Angiotensinogen Gene, AGT, and the Aldosterone Synthase Gene, CYP11B2 in Cardiovascular Diseases
por: Takeda, Yoshimichi, et al.
Publicado: (2021)

Tetra-ARMS PCR analysis of angiotensinogen AGT T174M (rs4762) genetic polymorphism in diabetic patients: a comprehensive study
por: Akash, Muhammad Sajid Hamid, et al.
Publicado: (2023)

Ligand conjugated antisense oligonucleotide for the treatment of transthyretin amyloidosis: preclinical and phase 1 data
por: Viney, Nicholas J., et al.
Publicado: (2020)

Maternal angiotensinogen (AGT) haplotypes, fetal renin (REN) haplotypes and risk of preeclampsia; estimation of gene-gene interaction from family-triad data
por: Vefring, Hege K, et al.
Publicado: (2010)

Increased urinary Angiotensinogen/Creatinine (AGT/Cr) ratio may be associated with reduced renal function in autosomal dominant polycystic kidney disease patients
por: Park, Hayne Cho, et al.
Publicado: (2015)

Association of angiotensin-converting enzyme insertion/deletion (ACE I/D) and angiotensinogen (AGT M235T) polymorphisms with the risk of obesity in a Tunisian population
por: Khamlaoui, Wided, et al.
Publicado: (2020)

The effect of polymorphisms (M235T and T174M) on the angiotensinogen gene (AGT) in coronary artery disease in the Eastern Asian population: A systematic review and meta-analysis
por: Zhang, Qian, et al.
Publicado: (2022)

Misura del Flusso di Ioni Leggeri con l'Esperimento Spaziale AMS
por: Molino, K
Publicado: (1999)

Tau-targeting antisense oligonucleotide MAPT(Rx) in mild Alzheimer’s disease: a phase 1b, randomized, placebo-controlled trial
por: Mummery, Catherine J., et al.
Publicado: (2023)

Safety and durability of AGT103-T autologous T cell therapy for HIV infection in a Phase 1 trial
por: Muvarak, Nidal, et al.
Publicado: (2022)

N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels
por: Alexander, Veronica J, et al.
Publicado: (2019)

Correlazioni di particelle in collisioni di ioni pesanti per l'esperimento ALICE a LHC
por: Noferini, Francesco
Publicado: (2012)

Integrated Assessment of the Clinical Performance of GalNAc(3)-Conjugated 2′-O-Methoxyethyl Chimeric Antisense Oligonucleotides: I. Human Volunteer Experience
por: Crooke, Stanley T., et al.
Publicado: (2019)

Treatment with Volanesorsen, a 2′-O-Methoxyethyl-Modified Antisense Oligonucleotide Targeting APOC3 mRNA, Does Not Affect the QTc Interval in Healthy Volunteers
por: Watts, Lynnetta M., et al.
Publicado: (2020)

Association between angiotensinogen (AGT), angiotensin-converting enzyme (ACE) and angiotensin-II receptor 1 (AGTR1) polymorphisms and COVID-19 infection in the southeast of Iran: a preliminary case-control study
por: Kouhpayeh, Hamid Reza, et al.
Publicado: (2021)

Structure and functions of angiotensinogen
por: Lu, Hong, et al.
Publicado: (2016)

Angiotensinogen and the Modulation of Blood Pressure
por: Shu, Zimei, et al.
Publicado: (2021)

Resolving the contributions of two cooperative mechanisms to the DNA Binding of AGT
por: Melikishvili, Manana, et al.
Publicado: (2015)

Quaternary interactions and supercoiling modulate the cooperative DNA binding of AGT
por: Melikishvili, Manana, et al.
Publicado: (2017)

Delivery of Therapeutic AGT shRNA by PEG-Bu for Hypertension Therapy
por: Wang, Yu-Qiang, et al.
Publicado: (2013)

Angiotensinogen Gene Transcription in Pulmonary Fibrosis
por: Uhal, Bruce D., et al.
Publicado: (2012)

Urinary Angiotensinogen Is Elevated in Patients with Nephrolithiasis
por: Sun, Wei, et al.
Publicado: (2014)

Correction: Corrigendum: Structure and functions of angiotensinogen
por: Lu, Hong, et al.
Publicado: (2016)

The Urinary Angiotensinogen to Urinary Albumin Ratio Reflects Whether the Renin-angiotensin System in the Kidney Is Activated due to Filtration of Plasma Angiotensinogen through the Damaged Glomeruli or the Production of Angiotensinogen in the Proximal Tubules
por: Ohashi, Naro, et al.
Publicado: (2019)

Rx.NET in action
por: Dresher, Tamir
Publicado: (2017)

RxJS in action
por: Daniels, Paul P, et al.
Publicado: (2017)

RxJava essentials
por: Morgillo, Ivan
Publicado: (2015)

Learning RxJava
por: Samoylov, Nick
Publicado: (2020)

Rx—The Eye of Horus
por: Walker, Clive
Publicado: (1992)

AGT M235T Genotype/Anxiety Interaction and Gender in the HyperGEN Study
por: Knox, Sarah S., et al.
Publicado: (2010)

Characterizing the in vivo role of trehalose in Saccharomyces cerevisiae using the AGT1 transporter
por: Gibney, Patrick A., et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_1fpojqv6o7i0q5a1rgibcr9o5j